A closer look at the cellular and molecular components of the deep/muscular fasciae

C Fede, C Pirri, C Fan, L Petrelli, D Guidolin… - International Journal of …, 2021 - mdpi.com
The fascia can be defined as a dynamic highly complex connective tissue network
composed of different types of cells embedded in the extracellular matrix and nervous fibers …

[HTML][HTML] Pharmacotherapies in dupuytren disease: current and novel strategies

AG Lambi, SN Popoff, P Benhaim, MF Barbe - The Journal of hand surgery, 2023 - Elsevier
Dupuytren disease is a benign, progressive fibroproliferative disorder of the hands. To date,
only one pharmacotherapy (clostridial collagenase) has been approved for use in …

Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren's disease—a randomized controlled …

K Knobloch, M Hellweg, H Sorg, T Nedelka - Lasers in Medical Science, 2022 - Springer
Dupuytren's disease is a progressive fibroproliferative disorder of the hand. In the nodular
stage of Dupuytren's disease, pain might limit daily hand activities and progress to finger …

Fascial plane blocks: from microanatomy to clinical applications

C Pirri, DE Torre, C Stecco - Current Opinion in Anesthesiology, 2024 - journals.lww.com
Current Opinion in Anesthesiology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …

Current concepts in the management of Dupuytren disease of the hand

JA Gil, MR Akelman, AM Hresko… - JAAOS-Journal of the …, 2021 - journals.lww.com
Dupuytren disease is a fibroproliferative disorder of the palmar fascia of the hand. Little
agreement and remarkable variability exists in treatment algorithms between surgeons …

Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease-derived fibroblasts

C Zhou, Y Zeldin, ME Baratz, S Kathju… - BMC Musculoskeletal …, 2019 - Springer
Background Dupuytren's disease (DD) is a progressive, debilitating condition of the hand
that can eventually cause contractures of the affected fingers. Transforming growth factor-β1 …

Analysis of recurrence and complications after percutaneous needle fasciotomy in Dupuytren's disease

P Moog, L Buchner, MK Cerny, D Schmauss… - Archives of Orthopaedic …, 2019 - Springer
Introduction The partial aponeurectomy for treatment of Dupuytren's contracture represents
the gold standard for treatment of Dupuytren's contracture. In selected cases, the alternative …

[HTML][HTML] Let's Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target

AG Lambi, NT Morrell, SN Popoff, P Benhaim… - Journal of Hand Surgery …, 2023 - Elsevier
Dupuytren disease is a progressive, benign fibroproliferative disorder of the hands that can
lead to debilitating hand contractures. Once symptomatic, treatment involves either surgical …

A Genome-Wide Association Study and Rare Variant Analysis for Dupuytren Disease in a North American Population

LC Grandizio, DT Smelser, JS Haley, S Delma… - The Journal of Hand …, 2024 - Elsevier
Purpose Although European genome-wide association studies (GWAS) have aided in
defining genetic associations in Dupuytren disease (DD), North American populations have …

The role of functional polymorphisms in the extracellular matrix modulation-related genes on Dupuytren's contracture

G Samulenas, R Insodaite, E Kunceviciene… - Genes, 2022 - mdpi.com
(1) Background: genetic variations, localized in the functional regions of the extracellular
matrix (ECM) modulation-related genes, may alter the transcription process and impact the …